Abstract:Background: The ability to generate functional hepatocytes without relying on donor liver organs holds significant therapeutic promise in the fields of regenerative medicine and potential liver disease treatments. Clustered regularly interspaced short palindromic repeats (CRISPR) activator (CRISPRa) is a powerful tool that can conveniently and efficiently activate the expression of multiple endogenous genes simultaneously, providing a new strategy for cell fate determination. The main purpose of this study is to explore the feasibility of applying CRISPRa for hepatocyte reprogramming and its application in the treatment of mouse liver fibrosis. Method: The differentiation of mouse embryonic fibroblasts (MEFs) into functional induced hepatocyte-like cells (iHeps) was achieved by utilizing the CRISPRa synergistic activation mediator (SAM) system, which drove the combined expression of three endogenous transcription factors—Gata4, Foxa3, and Hnf1a—or alternatively, the expression of two transcription factors, Gata4 and Foxa3. In vivo, we injected adeno-associated virus serotype 6 (AAV6) carrying the CRISPRa SAM system into liver fibrotic Col1a1-CreER; Cas9fl/fl mice, effectively activating the expression of endogenous Gata4 and Foxa3 in fibroblasts. The endogenous transcriptional activation of genes was confirmed using real-time quantitative polymerase chain reaction (RT-qPCR) and RNA-seq, and the morphology and characteristics of the induced hepatocytes were observed through microscopy. The level of hepatocyte reprogramming in vivo is detected by immunofluorescence staining, while the improvement of liver fibrosis is evaluated through Sirius red staining, alpha-smooth muscle actin (α-SMA) immunofluorescence staining, and blood alanine aminotransferase (ALT) examination. Results: Activation of only two factors, Gata4 and Foxa3, via CRISPRa was sufficient to successfully induce the transformation of MEFs into iHeps. These iHeps could be expanded in vitro and displayed functional characteristics similar to those of mature hepatocytes, such as drug metabolism and glycogen storage. Additionally, AAV6-based delivery of the CRISPRa SAM system effectively induced the hepatic reprogramming from fibroblasts in mice with live fibrosis. After 8 weeks of induction, the reprogrammed hepatocytes comprised 0.87% of the total hepatocyte population in the mice, significantly reducing liver fibrosis. Conclusion: CRISPRa-induced hepatocyte reprogramming may be a promising strategy for generating functional hepatocytes and treating liver fibrosis caused by hepatic diseases.

Oct4-mediated dedifferentiation of primary liver cells in mice

The Direct Oct4-mediated Primary Liver Cells in Mice Reprogramming of Pdx-1 Positive Cells

Efficient Generation of Functional Hepatocyte-Like Cells from Mouse Liver Progenitor Cells Via Indirect Co-Culture with Immortalized Human Hepatic Stellate Cells.

Small Molecules Facilitate the Reprogramming of Mouse Fibroblasts into Pancreatic Lineages

Induction of Hepatocyte-Like Cells from Mouse Embryonic Stem Cells by Lentivirus-Mediated Constitutive Expression of Foxa2/Hnf4a.

Reprogramming liver-stem WB cells into functional insulin-producing cells by persistent expression of Pdx1- and Pdx1-VP16 mediated by lentiviral vectors

In vivo direct reprogramming of liver cells to insulin producing cells by virus-free overexpression of defined factors.

Developing a Sensitive Reporter System for Monitoring of Pancreatic and Duodenal Homeobox Gene 1 (pdx1) and Neurogenin 3 (ngn3) – Mediated Transdifferentiation from Human Hepatic Cells into Insulin-Producing Beta-Like Cells

In vivo partial cellular reprogramming enhances liver plasticity and regeneration

Functional characteristics of reversibly immortalized hepatic progenitor cells derived from mouse embryonic liver.

The reprogrammed pancreatic progenitor-like intermediate state of hepatic cells is more susceptible to pancreatic beta cell differentiation.

In Vitro Cultivation and Differentiation of Fetal Liver Stem Cells from Mice

Direct reprogramming of fibroblasts into functional hepatocytes via CRISPRa activation of endogenous Gata4 and Foxa3

The Key Regulation of Mir-124-3p During Reprogramming of Primary Mouse Hepatocytes into Insulin-Producing Cells

Role of Pax4 in Pdx1-VP16-mediated Liver-to-endocrine Pancreas Transdifferentiation

Conversion of Immortal Liver Progenitor Cells into Pancreatic Endocrine Progenitor Cells by Persistent Expression of Pdx‐1

In vitro differentiation of hepatic progenitor cells from mouse embryonic stem cells induced by sodium butyrate.

Hepatic Differentiation of Liver-Derived Progenitor Cells and Their Characterization by Microrna Analysis

In vitro differentiation of embryonic stem cells into hepatocytes induced by fibroblast growth factors and bone morphological protein-4.

Reprogramming Fibroblasts into Bipotential Hepatic Stem Cells by Defined Factors

Induction of Hepatocytes-Derived Insulin-Producing Cells Using Small Molecules and Identification of Microrna Profiles During This Procedure.